-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_surveillance.pdf
January 15, 2013 - In the second
model, Phe and IQ were measured
concurrently (within 6 weeks of
each other). … In the RCT, at a dosage
of 20
mg/kg/day over 10 weeks,
participants in the treatment group
increased … ) doubling
of natural protein intake
Phase 3: (4 weeks) daily BH4
(20mg/kg) with increase
natural … In the
second model, Phe and IQ were measured
concurrently (within 6 weeks of each other). … In the RCT, at a dosage of 20
mg/kg/day over 10 weeks, participants in
the treatment group increased
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-report-3-acute-pain.pdf
June 01, 2022 - ; 2
weeks to less than 4 weeks; 4 weeks or longer? … ; 2 weeks to
less than 4 weeks; 4 weeks or longer? … ; 2 weeks to less than 4 weeks; 4 weeks or longer? … ; 2
weeks to less than 4 weeks; 4 weeks or longer? … ; 2 weeks to 4 weeks;
≥4 weeks
NOTE: There will not be exclusion criteria for
duration, unless duration
-
effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-ape_0.xlsx
August 08, 2017 - of Pain Demographics Other Population Characteristics N Randomized
N Analyzed Intervention Duration (weeks … Placebo (n=194) 12 to 24 [95% of placebo and 5% of Ibuprofen discontinued at 16 weeks] NR
Hawkey, 2004 … Carrier
Topical diclofenac vs. carrier (6 to 12 weeks)
Pain responder: 716/1185 (60%) vs. 582/1158 ( … ): 0.00 (-0.10 to 0.10)
Pain (>24 weeks): MD -2.00 (-5.32 to 1.32)
Function (<24 weeks): 006 (-0.09 to … 0.21)
Celecoxib vs. naproxen SMD (95% CI)
Pain (≤24 weeks): -0.04 (-0.14 to 0.05)
Function (≤24 weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-202-bronchial-thermoplasty-asthma.pdf
December 01, 2017 - BT is usually given as three treatments
3 weeks apart. … bronchoscopic procedure and
standard care after the treatment period was complete
(3 procedures over 6 weeks … , followed by an additional 6
weeks) through the 12-month followup (post-treatment
period), but the … The risk of adverse events is higher early in treatment,
while benefit is typically observed weeks to
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0405_01-16-2011.pdf
January 01, 2011 - s): Adults (age 18 years and older) and adolescents (age 14 to 18 years)
with cough of more than 8 weeks … ’ duration; children (age 14 years and younger) with
cough of more than 3 weeks’ duration.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-social-isolation-older-adults-final.pdf
February 01, 2019 - of the 1-year time span for potential visits aligned with these 15 weeks. … One study41 measured outcomes at 3
weeks, which was too short to see an effect on certain important … • 24 weeks
Comparator
• For 24 weeks, received no
training. … • The program was delivered by 3
nurses and 3 social workers
• 1.5 hours a week for 15 weeks. … At 3 weeks:
• No significant effect
on quality of life or
self-esteem.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
April 01, 2011 - This study included 828 moderate to severe
asthmatics with reflux symptoms and utilized 24 weeks of … Kathleen Gans-
Brangs, PhD;
AstraZeneca
Results “In two studies of 4 weeks and 6 months duration, … Recommend "In two
studies of 4 weeks and 6 months duration, heartburn control with
dexlansoprazole … Of the 66 patients with GERD, 85% (56/66) received
lansoprazole for 8 weeks and 15% (10/66) for 12 weeks … 10 weeks,
and 1% (1/87) for greater than 10 weeks.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_executive.pdf
September 22, 2011 - Dual therapy is
typically administered for 24 weeks in
patients infected with HCV genotype
2 or 3 … and on two of three measures at 12 weeks. … (86.4% compared with 77.7%; p=0.01) and
24 weeks (71.4% compared with 62.4%; p=0.045). … At 24 weeks,
there was a statistically significantly greater mean number
of missed doses among the … and
24 weeks for those with genotypes 2 and 3.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
April 25, 2022 - postpartum, but postpartum visits are commonly scheduled relatively late (e.g., at 4 to 6 weeks after … ACOG) Committee Opinion
recommends an initial interaction with the clinical care provider within 3 weeks … postpartum.18
However, most postpartum deaths occur before 12 weeks postpartum, and therefore having … the
comprehensive visit at 12 weeks may be too late. … postpartum, and between
6 weeks and 3 months postpartum?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
May 07, 2010 - versus a direct renin inhibitor
For all included studies, please also indicate the longest length (weeks … or # months follow-up, or write “NS” if length of
follow-up not specified)
- IN AcVR (specify # weeks … or # months follow-up, or write “NS” if length of
follow-up not specified)
- IN ArVR (specify # weeks … non-RCTs, cohorts, etc.); cross-sectional
studies acceptable if time on treatment reported and ≥ 12 weeks … Treatment duration/length of followup:
- Exclude if treatment duration or longest followup < 12 weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
September 30, 2015 - Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality
Hruschak, 2021 RCT
Duration: 6 weeks … , adjusted for race and depression)
Pain severity (0 to 10): 7.15 (SD 2.38) vs. 7.36 (SD 1.55) at 9 weeks … , mean difference -9.20 (95% CI -20.25 to 1.85)* NR NR Fair
Maheu, 2022 RCT
Duration: 12 weeks; optional … B
8 weeks
Pain intensity (NRS 0 to 10, LSM change at followup): -2.7 (SE 0.1) vs. -2.5 (SE 0.1)
Pain … B, at 8 weeks
Pain intensity (WOMAC 0 to 10 NRS, mean change from baseline): –2.17 (0.24) vs. –2.28 (
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_consumer.pdf
August 01, 2015 - You may
need several days or weeks of radiation therapy before cancer cells
start to die. … Cancer cells will keep dying for weeks or months after
radiation therapy ends. … stage of your head and neck cancer
� Your age
Types of side effects
Side effects can appear around 2 weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_surveillance.pdf
April 01, 2016 - adjunct were
associated with improvement on the Clinical Global
Impressions (CGI) scale at 8 and 52 weeks … Both MBCT and HEP
as an adjunct were associated with improvement on the CGI at 8 and 52 weeks. … At 52
weeks, MBCT was
associated with a larger
percentage of treatment
responses, but not a … groups.
2
to be associated better
outcomes than HEP at 8
weeks. … Both MBCT and
HEP were associated with
improvement on the CGI at
eight and 52 weeks.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment-future_research.pdf
January 01, 2014 - We defined
chronic venous leg ulcers as active, noninfected ulcers present for 6 weeks or more with … • Timing: The healing rate should be assessed at 4 weeks, and 12 weeks is accepted as a
standard … • Timing: The healing rate should be assessed at 4 weeks, and 12 weeks is accepted as a
standard … • Timing: The healing rate should be assessed at 4 weeks, and 12 weeks is accepted as a
standard … • Timing: Twelve weeks is accepted as a standard for evaluating wound healing.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-executive-summary.pdf
August 01, 2024 - 0.71 (95% CI, 0.53-0.95,
median follow up: 42 months and similar
in both arms)
Moderate
CR (6 weeks … Low
CR (4-6 weeks
post treatment)
1; RCTs; n=310 No significant difference, precise … Low
CR (at 26 weeks
posttreatment)
1; RCT; n=144 Significantly greater in the paclitaxel arm
vs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
September 01, 2009 - Randomized controlled trials for all
outcomes and nonrandomized comparative studies of
24 weeks or more … Trials of
greater than 24 weeks duration were defined as long
term, while those less than 24 weeks were … no differences were detected when
analyses were restricted to the few long-term trials of
24 to 52 weeks … We restricted
our focus to studies of 24 weeks or longer that reported
clinical efficacy outcomes, the … Only one trial
provided evidence on a clinical outcome of interest over
a minimum period of 24 weeks.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_surveillance.pdf
October 01, 2012 - Most gains remained
14 weeks post treatment
(Laugeson, 2011). … mediated
joint engagement vs
wait list 38 toddlers w ASD
24 caregiver-mediated
sessions over 8 weeks … At 8 weeks, there was greater
improvement on 2 of 3 joint
engagement outcomes, one of
two joint … and anxiety-related
issues, aged 9 to 16
years
One 90 minute group
session per week, for 16
weeks … At 14 weeks
post tx the vast majority of tx
gains were maintained.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth-disposition-121205.pdf
September 07, 2012 - Thus the 7.7 percent result includes
some miscarriages after 16 weeks. … However, the appropriateness of using 37 weeks as a primary
endpoint was not considered an adequate … gestation with a range of 15
to 36 weeks”. … Is it reasonable to include the study that enrolled
patients at 36 weeks in this analysis? … Thus the 7.7 percent result includes
some miscarriages after 16 weeks.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
September 01, 2012 - Preterm Birth
Executive Summary
Introduction
Burden of Preterm Birth
Birth before completion of 37 weeks … In pregnant women who are at risk for preterm birth
(which is birth before 37 weeks gestational age) … consistent
findings indicates lack of effectiveness for multiple
gestations (preterm birth at < 35 weeks … The majority initiated
treatment between 16 and 21 weeks. … and n=208) and one retrospective
cohort (n=906) compared initiating 17OHP before, versus
after, 21 weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-3-nonopioid-pharm-chronic-pain.pdf
July 01, 2022 - response (34.1% vs. 29.3%, p=0.369), or function on the RMDQ (approximate MD -0.4,
p=0.305) after 12 weeks … Incidence of gastroduodenal ulcers in
patients with rheumatoid arthritis after 12
weeks of rofecoxib … ; DPN=diabetic painful neuropathy; mg=milligrams; NPP=neuropathic pain;
SD=standard deviation; wks=weeks … =day; FM=fibromyalgia; mg=milligrams; SD=standard deviation; SMD=standardized
mean difference; wks=weeks … SNRI=selective
serotonin and norepinephrine reuptake inhibitor; TCA=tricyclic antidepressants; wks=weeks